Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Subtransverse Interligamentary Block Versus Paravertebral Block for Quality of Recovery After Mastectomy

NCT07647367 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2026-06-20
Last updated
2026-08-04

Condition(s) studied

Quality of Recovery (QoR-15)Modified Radical Mastectomy

Investigational drug(s) / intervention(s)

Subtransverse interligamentary plane block (STIL)Thoracic paravertebral block (TPVB)

Subtransverse interligamentary plane block (STIL): Patients will receieve u;trasound guided subtransverse interligamentary plane block

Thoracic paravertebral block (TPVB): Patients will receieve ultrasound guided thoracic paravertebral block

Study summary

This prospective randomized controlled double blinded non-inferiority study will be carried out in Tanta University Hospitals for duration of 6 months from June 2026 to December 2026 on 60 female patients scheduled for unilatral modified radical mastectomy under general anesthesia.

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: * Adult female patients aged 18 to 65 years with American Society of Anesthesiologists (ASA) Physical Status I - III, who were scheduled for unilateral MRM surgery under general anesthesia and able to understand and complete the QoR-15 questionnaire Exclusion Criteria: * • Patients declined to participate in the trial. * History of allergy to the used local anesthetic (LA) drugs. * Patients with cutaneous lesions at the needle entry point. * Coagulopathy or current anticoagulant therapy contraindicating regional block. * Patients with severe hepatic, renal, cardiac, or respiratory disease. * Psychiatric or cognitive disorder interfering with QoR-15 assessment * Chronic opioid use or chronic pain syndrome. * Failed block. * Morbid obesity (body mass index \>40 kg/m2) * Intraoperative major complications requiring postoperative ICU admission. * Pregnancy

Primary outcome measure(s)

  • Postoperative quality of recovery — It will be measured 24 hours after surgery
    Postoperative quality of recovery assessed using the Quality of Recovery-15 questionnaire which provides a global score of recovery after anesthesia and surgery by evaluating pain, comfort, emotions, independence, and support. The total score ranges from 0 to 150. Higher score = better recovery.

Trial sites (2)

FacilityCityRegionStatus
Tanta university hospital Tanta Gharbia Governorate Recruiting
Tanta university hospital Tanta Egypt Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07647367 on ClinicalTrials.gov ↗ ← All trials in Egypt